The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell
- PMID: 20089699
- DOI: 10.4049/jimmunol.0901570
The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell
Abstract
Exchange of plasma membrane fragments, including cell-surface proteins and lipids, in conjugates formed between lymphocytes and their cellular partners is a field of intense investigation. Apart from its natural occurrence during Ag recognition, the process of membrane transfer can be triggered in experimental or therapeutic settings when lymphocytes targeted by Abs are conjugated to FcgammaR-expressing accessory cells. The direction of membrane capture (i.e., which of the two cells is going to donate or accept plasma membrane fragments) can have important functional consequences, such as insensitivity of tumor cells to treatment by therapeutic mAbs. This effect, called antigenic modulation or shaving, occurs as a result of a process in which the FcgammaR-expressing cells remove the mAb and its target protein from the tumor cells. We therefore analyzed this process in conjugates formed between various FcgammaR-expressing cells and a series of normal or tumor T and B cells opsonized with different Abs capable of triggering membrane exchange (including the therapeutic Ab rituximab). Our results show that the direction of membrane capture is dictated by the identity of the FcgammaR-expressing cell, much more so than the type of lymphocyte or the Ab used. We found that monocytes and macrophages are prone to be involved in bidirectional trogocytosis with opsonized target cells, a process they can perform in parallel to phagocytosis. Our observations open new perspectives to understand the mechanisms involved in trogocytosis and may contribute to optimization of Ab-based immunotherapeutic approaches.
Similar articles
-
Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis.J Immunol. 2009 Nov 15;183(10):6102-13. doi: 10.4049/jimmunol.0900821. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841164
-
Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.J Immunol. 2011 Sep 15;187(6):3438-47. doi: 10.4049/jimmunol.1101189. Epub 2011 Aug 12. J Immunol. 2011. PMID: 21841127
-
Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis.J Immunol. 2009 Nov 1;183(9):5622-9. doi: 10.4049/jimmunol.0901772. J Immunol. 2009. PMID: 19843947
-
Gnawing Between Cells and Cells in the Immune System: Friend or Foe? A Review of Trogocytosis.Front Immunol. 2022 Feb 3;13:791006. doi: 10.3389/fimmu.2022.791006. eCollection 2022. Front Immunol. 2022. PMID: 35185886 Free PMC article. Review.
-
Biting Off What Can Be Chewed: Trogocytosis in Health, Infection, and Disease.Infect Immun. 2020 Jun 22;88(7):e00930-19. doi: 10.1128/IAI.00930-19. Print 2020 Jun 22. Infect Immun. 2020. PMID: 32366574 Free PMC article. Review.
Cited by
-
Circulating T cell-monocyte complexes are markers of immune perturbations.Elife. 2019 Jun 25;8:e46045. doi: 10.7554/eLife.46045. Elife. 2019. PMID: 31237234 Free PMC article.
-
Dynamics of macrophage trogocytosis of rituximab-coated B cells.PLoS One. 2011 Jan 17;6(1):e14498. doi: 10.1371/journal.pone.0014498. PLoS One. 2011. PMID: 21264210 Free PMC article.
-
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.Sci Adv. 2022 Apr 15;8(15):eabj3286. doi: 10.1126/sciadv.abj3286. Epub 2022 Apr 13. Sci Adv. 2022. PMID: 35417234 Free PMC article.
-
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.Front Immunol. 2024 Jan 22;14:1307873. doi: 10.3389/fimmu.2023.1307873. eCollection 2023. Front Immunol. 2024. PMID: 38318505 Free PMC article.
-
Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.J Immunol. 2014 Feb 15;192(4):1620-9. doi: 10.4049/jimmunol.1302954. Epub 2014 Jan 15. J Immunol. 2014. PMID: 24431228 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources